FDA Expands use of Ferric Maltol for Adolescents with Iron Deficiency We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
FDA Approves First Treatment for HSCT-Associated Thrombotic Microangiopathy We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
WASHINGTON — Vaccine policy has become a key issue for the Trump administration, especially under the leadership of health secretary Robert F. Kennedy Jr., who himself once led an anti-vaccine group. In less than a year, Kennedy has bulldozed vaccine policy precedent and government personnel. The Centers for Disease Control and Prevention and the Food…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. The NIH director did the Pete & Bobby fitness challenge, but I didn’t see Jay Bhattacharya do any pull-ups. And you can decide what…
FDA Clears cranial electrotherapy stimulation device for Home-Based Treatment of Major Depressive Disorder We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
WASHINGTON — The Food and Drug Administration is in a precarious position as it heads toward 2026. The agency has been mired by high-profile departures, feuds between top leaders, accusations of politicization, and low morale. It has lost thousands of employees to layoffs and resignations and cannot seem to hold onto a director of the…
The FDA’s priority review voucher program was designed to encourage the development of drugs for neglected diseases. Still, it has evolved into a mechanism that invites political interference in drug review decisions. By prioritizing speed under political and financial pressure, the program risks weakening scientific standards, undermining FDA independence, and exposing patients to unsafe or…
FDA Approves Depemokimab-ulaa as First Twice-Yearly Biologic for Severe Eosinophilic Asthma We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
FDA Approves Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
WASHINGTON — A new program intended to fast-track drug reviews at the Food and Drug Administration is quickly becoming a way for the White House and top political officials at the agency to exert control over which medicines make their way fastest to patients in the United States. The FDA has historically aimed to keep…